| 2026-05-16 | Presentation | Corporate Presentation, May 2026
View Presentation |
| 2026-05-14 | Press release | Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update View Press Release |
| 2026-05-14 | Press release | PDF |
| 2026-04-28 | Press release | Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Con |
| 2026-04-22 | Presentation | Durable Responses to Low Dose BB-301 in Oculopharyngeal Muscular Dystrophy at 12- and 24-months and Improved Depth of Response to High Dose BB-301 |
| 2026-04-21 | Presentation | Corporate Presentation, March 2026 |
| 2026-03-10 | Press release | Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scienti |
| 2026-03-09 | Press release | Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements |
| 2026-02-23 | Press release | Benitec Biopharma Announces Acceptance of Late- Breaking Abstract for the BB-301 Phase 1b/2a Clinical Treatment Study at |
| 2026-02-12 | Press release | Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update |
| 2026-02-12 | Press release | Earnings Release Q2 2026 PDF |
| 2026-01-11 | Press release | Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating |
| 2026-01-11 | Presentation | Corporate Presentation, January 2026 |
| 2025-11-14 | Press release | Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update |
| 2025-11-14 | Press release | Earnings Release Q1 2026 PDF |
| 2025-11-03 | Presentation | Positive Clinical Data Supporting Advancement of BB-301 in OPMD |
| 2025-11-02 | Press release | Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy |
| Press release | Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update |
| 2025-09-22 | Press release | Earnings Release FY 2025 PDF |
| 2025-09-01 | Presentation | Corporate presentation, September 2025 |
| Press release | Benitec Biopharma Provides Operational Updates |
| Press release | Benitec Biopharma Releases Third Quarter 2025 Financial Results |
| 2025-03-19 | Presentation | Interim Study Update for BB-301 Gene Therapy Phase 1b/2a First in Human Trial in Subjects with Oculopharyngeal Muscular Dystrophy with Dysphagia |
| 2025-03-05 | Presentation | Corporate Presentation, March 2025 |
| 2025-02-26 | Press release | Benitec Biopharma to Participate in Upcoming Conferences in March |
| Press release | Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update |
| 2025-02-14 | Press release | Earnings Release Q2 2025 PDF |
| Press release | Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update |
| Press release | Benitec Biopharma Announces Updated Investor Webcast Information |
| 2024-10-14 | Presentation | Interim Clinical Data Summary for Subject One and Two |
| 2024-09-26 | Press release | Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update |
| 2024-09-26 | Press release | Earnings Release FY 2024 PDF |
| 2024-05-13 | Press release | Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update |
| 2024-04-18 | Presentation | Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy |
| 2024-02-13 | Press release | Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update |
| 2023-11-13 | Press release | Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update |
| 2023-09-21 | Press release | Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update |
| 2023-05-15 | Press release | Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update |
| 2023-02-13 | Press release | Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational Update |
| 2022-11-10 | Press release | Benitec Biopharma Releases First Quarter 2023 Financial Results and Provides Operational Update |